-
EP2097105
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2097105
| EP2097105 - ANTI-P-SELECTIN ANTIBODIES AND METHODS OF USING THE SAME TO TREAT INFLAMMATORY DISEASES [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 25.01.2019 Database last updated on 29.03.2025 | Most recent event Tooltip | 25.01.2019 | Withdrawal of application | published on 27.02.2019 [2019/09] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | For all designated states Oklahoma Medical Research Foundation 825 N.E. 13th Street Oklahoma City, OK 73104 / US | [2018/52] |
| Former [2018/51] | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | ||
| Former [2009/37] | For all designated states Selexys Pharmaceuticals Corporation 800 Research Parkway Suite 338 Oklahoma City OK 73104 / US | Inventor(s) | 01 /
MCEVER, Rodger P. 1716 Guildford Lane Oklahoma City, OK 73120 / US | 02 /
ALVAREZ, Richard 3604 Katherine Court Edmond, OK 73013 / US | 03 /
KAWAR, Ziad 333 N.W. 5th Street, Apt. 1802 Oklahoma City, OK 73102 / US | [2009/37] | Representative(s) | HGF 4th Floor Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | [N/P] |
| Former [2014/07] | Armstrong, Iain Cheshire, et al Harrison Goddard Foote LLP 4th Floor, Merchant Exchange 17-19 Whitworth Street West Manchester M1 5WG / GB | ||
| Former [2009/37] | Harrison Goddard Foote Belgrave Hall Belgrave Street Leeds LS2 8DD / GB | Application number, filing date | 07867601.2 | 30.11.2007 | [2009/37] | WO2007US24692 | Priority number, date | US20060872170P | 01.12.2006 Original published format: US 872170 P | [2009/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008069999 | Date: | 12.06.2008 | Language: | EN | [2008/24] | Type: | A2 Application without search report | No.: | EP2097105 | Date: | 09.09.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.06.2008 takes the place of the publication of the European patent application. | [2009/37] | Search report(s) | International search report - published on: | US | 04.12.2008 | (Supplementary) European search report - dispatched on: | EP | 17.08.2010 | Classification | IPC: | A61K39/395, C07K16/28 | [2009/37] | CPC: |
C07K16/2854 (EP,US);
C07K16/28 (US);
A61P11/06 (EP);
A61P25/04 (EP);
A61P9/00 (EP);
C07K2317/24 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/37] | Title | German: | ANTI-P-SELEKTIN-ANTIKÖRPER UND VERFAHREN ZU IHRER VERWENDUNG FÜR DIE BEHANDLUNG VON ENTZÜNDUNGSERKRANKUNGEN | [2009/37] | English: | ANTI-P-SELECTIN ANTIBODIES AND METHODS OF USING THE SAME TO TREAT INFLAMMATORY DISEASES | [2009/37] | French: | ANTICORPS ANTI-P-SELECTINE ET PROCEDES POUR LES UTILISER DANS LE TRAITEMENT DES MALADIES INFLAMMATOIRES | [2009/37] | Entry into regional phase | 29.06.2009 | National basic fee paid | 29.06.2009 | Search fee paid | 29.06.2009 | Designation fee(s) paid | 29.06.2009 | Examination fee paid | Examination procedure | 29.06.2009 | Examination requested [2009/37] | 07.03.2011 | Amendment by applicant (claims and/or description) | 21.04.2011 | Despatch of a communication from the examining division (Time limit: M06) | 20.10.2011 | Reply to a communication from the examining division | 24.01.2012 | Invitation to indicate the basis for amendments (Time limit: M01) | 15.02.2012 | Reply to an invitation to indicate the basis for amendments | 18.06.2013 | Cancellation of oral proceeding that was planned for 19.06.2013 | 19.06.2013 | Date of oral proceedings (cancelled) | 02.07.2013 | Despatch of communication that the application is refused, reason: substantive examination {1} | 13.12.2018 | Application withdrawn by applicant [2019/09] | Appeal following examination | 30.08.2013 | Appeal received No. T2317/13 | 13.11.2013 | Statement of grounds filed | 13.12.2018 | Result of appeal procedure: the application was withdrawn | Divisional application(s) | EP13164403.1 / EP2662091 | EP18211423.1 / EP3501538 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 21.04.2011 | Fees paid | Renewal fee | 25.11.2009 | Renewal fee patent year 03 | 15.12.2010 | Renewal fee patent year 04 | 14.11.2011 | Renewal fee patent year 05 | 25.09.2012 | Renewal fee patent year 06 | 03.09.2013 | Renewal fee patent year 07 | 27.10.2014 | Renewal fee patent year 08 | 05.10.2015 | Renewal fee patent year 09 | 08.11.2016 | Renewal fee patent year 10 | 13.11.2017 | Renewal fee patent year 11 | 14.11.2018 | Renewal fee patent year 12 | Penalty fee | Additional fee for renewal fee | 30.11.2010 | 04 M06 Fee paid on 15.12.2010 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO9321956 (CYTEL CORP [US], et al); | [I]WO9533484 (BLOOD RES CENTER [US]); | [I]WO9534324 (PROTEIN DESIGN LABS INC [US], et al); | [I]WO2005100402 (HOFFMANN LA ROCHE [CH], et al); | International search | [Y]US5800815 (CHESTNUT ROBERT W [US], et al); | [Y]US6667036 (CUMMINGS RICHARD D [US], et al) | Examination | WO2004056312 |